For presentation materials, click here.

Financial institutions in Europe and the US are considering a range of products to address their funding needs. It's a difficult task, as it's still not known which products will receive beneficial regulatory capital treatment. National regulators also have provided guidance on additional or so-called buffer capital, as well as contingent capital products.

European banks have recently issued contingent capital products - or CoCos - and we expect additional offerings to be forthcoming. These issuances face an uncertain regulatory framework, and evolving market practice. This webinar will discuss these considerations, focusing on:

• Basel III guidance and status of implementation;
• Bail-in capital, including national guidance;
• Contingent capital products and structures;
• Market experience;
• Tax, ratings, corporate governance and other considerations relating to contingent capital; and
• Investor perspective.

Speakers:

• Thomas Humphreys, Morrison & Foerster LLP
• Anna Pinedo, Morrison & Foerster LLP
• Anthony Ragozino, UBS
• Danielle Myles (moderator), IFLR